QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
NASDAQ:AHCO

AdaptHealth (AHCO) Stock Forecast, Price & News

$10.30
-0.11 (-1.06%)
(As of 06/9/2023 ET)
Compare
Today's Range
$10.21
$10.46
50-Day Range
$10.00
$12.52
52-Week Range
$9.91
$27.48
Volume
994,223 shs
Average Volume
1.20 million shs
Market Capitalization
$1.38 billion
P/E Ratio
85.83
Dividend Yield
N/A
Price Target
$18.92

AdaptHealth MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.57 Rating Score
Upside/​Downside
83.7% Upside
$18.92 Price Target
Short Interest
Healthy
15.81% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.52mentions of AdaptHealth in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
20.59%
From $0.68 to $0.82 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.10 out of 5 stars

Medical Sector

11th out of 986 stocks

Home Health Care Services Industry

1st out of 8 stocks


AHCO stock logo

About AdaptHealth (NASDAQ:AHCO) Stock

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.

Receive AHCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter.

AHCO Stock News Headlines

AdaptHealth (NASDAQ:AHCO) Shares Up 6.1%
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
AdaptHealth Corp.
Stifel Nicolaus upgrades AdaptHealth (AHCO) to a Hold
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
AdaptHealth (NASDAQ:AHCO) Downgraded by Bank of America
Stifel Downgrades AdaptHealth (AHCO)
AdaptHealth (NASDAQ:AHCO) Reaches New 12-Month Low at $10.21
Stifel Nicolaus Downgrades AdaptHealth (NASDAQ:AHCO) to Hold
AdaptHealth Q1 2023 Earnings Preview
See More Headlines

AHCO Price History

AHCO Company Calendar

Last Earnings
11/04/2021
Today
6/09/2023
Next Earnings (Estimated)
8/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AHCO
Fax
N/A
Employees
10,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$18.92
High Stock Price Forecast
$30.00
Low Stock Price Forecast
$11.00
Forecasted Upside/Downside
+82.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.57
Research Coverage
7 Analysts

Profitability

Net Income
$69.32 million
Pretax Margin
2.16%

Debt

Sales & Book Value

Annual Sales
$3.00 billion
Cash Flow
$2.99 per share
Book Value
$16.01 per share

Miscellaneous

Free Float
110,960,000
Market Cap
$1.39 billion
Optionable
Not Optionable
Beta
0.64

Key Executives

  • Stephen P. GriggsStephen P. Griggs
    Chief Executive Officer & Director
  • Joshua Parnes
    President & Director
  • Shaw RietkerkShaw Rietkerk
    Chief Operating Officer
  • Jason A. ClemensJason A. Clemens
    Chief Financial Officer
  • Albert A. Prast
    Chief Technology Officer













AHCO Stock - Frequently Asked Questions

Should I buy or sell AdaptHealth stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last twelve months. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AHCO shares.
View AHCO analyst ratings
or view top-rated stocks.

What is AdaptHealth's stock price forecast for 2023?

7 Wall Street research analysts have issued twelve-month price targets for AdaptHealth's shares. Their AHCO share price forecasts range from $11.00 to $30.00. On average, they anticipate the company's share price to reach $18.92 in the next year. This suggests a possible upside of 82.5% from the stock's current price.
View analysts price targets for AHCO
or view top-rated stocks among Wall Street analysts.

How have AHCO shares performed in 2023?

AdaptHealth's stock was trading at $19.22 on January 1st, 2023. Since then, AHCO stock has decreased by 46.0% and is now trading at $10.37.
View the best growth stocks for 2023 here
.

Are investors shorting AdaptHealth?

AdaptHealth saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 11,640,000 shares, a decrease of 8.9% from the April 30th total of 12,780,000 shares. Based on an average trading volume of 1,510,000 shares, the days-to-cover ratio is presently 7.7 days. Approximately 15.8% of the shares of the stock are sold short.
View AdaptHealth's Short Interest
.

When is AdaptHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our AHCO earnings forecast
.

How were AdaptHealth's earnings last quarter?

AdaptHealth Corp. (NASDAQ:AHCO) posted its quarterly earnings data on Thursday, November, 4th. The company reported $0.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.28 by $0.08. The company earned $653.30 million during the quarter, compared to analyst estimates of $638.74 million. AdaptHealth had a net margin of 1.44% and a trailing twelve-month return on equity of 3.17%. The company's quarterly revenue was up 129.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.05 EPS.

What other stocks do shareholders of AdaptHealth own?
What is AdaptHealth's stock symbol?

AdaptHealth trades on the NASDAQ under the ticker symbol "AHCO."

Who are AdaptHealth's major shareholders?

AdaptHealth's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.81%), FMR LLC (7.27%), Truist Financial Corp (2.90%), Rubric Capital Management LP (2.46%), Sumitomo Mitsui Trust Holdings Inc. (2.44%) and State Street Corp (1.97%). Insiders that own company stock include Aero Holdings Ii Ll Skyknight, Alan G Quasha, Assured Investment Management, Christopher J Joyce, Dale B Wolf, Daniel Bunting, Everest Hill Group Inc, Frank Mullen, Jason A Clemens, Ronald T Mcdaniel, Shaw Rietkerk, Skyknight Capital Fund Ii, LP and Stephen P Griggs.
View institutional ownership trends
.

How do I buy shares of AdaptHealth?

Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AdaptHealth's stock price today?

One share of AHCO stock can currently be purchased for approximately $10.37.

How much money does AdaptHealth make?

AdaptHealth (NASDAQ:AHCO) has a market capitalization of $1.39 billion and generates $3.00 billion in revenue each year. The company earns $69.32 million in net income (profit) each year or $0.12 on an earnings per share basis.

How many employees does AdaptHealth have?

The company employs 10,900 workers across the globe.

How can I contact AdaptHealth?

AdaptHealth's mailing address is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. The official website for the company is www.adapthealth.com. The company can be reached via phone at (610) 424-4515 or via email at dsullivan@equityny.com.

This page (NASDAQ:AHCO) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -